|
English
|
正體中文
|
简体中文
|
2826152
|
|
???header.visitor??? :
31809429
???header.onlineuser??? :
864
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"schmitz shu fang hsu"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
國立臺灣大學 |
2015 |
First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M.
|
Tan, Daniel Shao-Weng; Seto, Takashi; Leighl, Natasha B.; Riely, Gregory J.; Sequist, Lecia V.; Felip, Enriqueta; Wolf, Juergen; Yang, James Chih-Hsin; Matushansky, Igor; Yu, Xiaolu; Schmitz, Shu-Fang Hsu; Cui, Xiaoming; Kim, Dong-Wan; 楊志新 |
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
|